Can Tarceva (erlotinib) cure lung cancer?
Tarceva (erlotinib) is not a cure for lung cancer. Tarceva is a type of targeted cancer therapy that is used in the treatment of advanced non-small cell lung cancer (NSCLC) that has spread. It may help to shrink tumors.
Tarceva helps prolong how long NSCLC patients live for without their cancer progressing (progression-free survival time) and also helps to increase the amount of time patients live with their cancer (overall survival time).
Tarceva has been approved by the US Food and Drug Administration (FDA) to treat patients with metastatic NSCLC whose tumors have epidermal growth factor receptor (EGFR) exon 19 deletions or exon 21 (L858R) substitution mutations. It is also approved for use in patients with pancreatic cancer.
References
- Food and Drug Administration (FDA). Tarceva Product Label. [Accessed November 23, 2022]. Available from: https://www.accessdata.fda.gov/drugsatfda_docs/label/2016/021743s025lbl.pdf.
Read next
How does erlotinib work (mechanism of action)?
Erlotinib works by blocking the epidermal growth factor receptor (EGFR), a protein on cells that encourages cancer cell growth. Continue reading
Is small cell or non-small cell lung cancer worse?
Generally, small cell lung cancer (SCLC) is worse than non-small cell lung cancer (NSCLC). SCLC accounts for about 10-15% of people who have lung cancer and is the most aggressive form of lung cancer. SCLC usually starts in the breathing tubes (bronchi), and although the cells are small, they grow very quickly and create large tumors. Early on in the course of the disease, there are rarely any symptoms. If caught early (limited-stage disease) 20-25% of people can be potentially cured. Extensive SCLC is more difficult to treat. Continue reading
Is non-small cell lung cancer hereditary?
A hereditary family history of lung cancer is one of the many risk factors for developing non-small cell lung cancer. About 8% of lung cancers are thought to be inherited or linked to gene changes, but smoking and air pollution remain the primary causes of lung cancer. Continue reading
Related medical questions
- How aggressive is non-small cell lung cancer?
- Does smoking cause non-small cell lung cancer?
- What type of lung cancer is Vizimpro used to treat?
- What type of cancer is Tecentriq used to treat?
- How long does it take for Keytruda to work?
- Why give Taxol (Paxel) before carboplatin?
- What is the difference between Opdivo and Keytruda?
- Pembrolizumab vs. nivolumab: How do they compare?
- What is Paxel called in the USA?
- How effective is Lumakras, what's the survival rate?
- What is the difference between Mvasi and Avastin?
- Are there cost-saving programs for Tecentriq?
- How effective is Tabrecta?
- How effective is atezolizumab (Tecentriq)?
- Opdivo vs Opdivo Qvantig: What is the Difference?
- Is atezolizumab (Tecentriq) a chemotherapy or immunotherapy drug?
- How long can I take Gilotrif (afatinib) for?
- Will Tabrecta cure lung cancer?
- How long do you take Alecensa for?
- Is Gilotrif (afatinib) a chemotherapy drug?
- How effective is Alecensa for ALK-positive NSCLC?
- How does Retevmo work?
- Is Tabrecta a chemotherapy drug?
- What is the mechanism of action for Alecensa (alectinib)?
- How does pemetrexed work?
- How do Exkivity and Rybrevant compare for NSCLC?
- How does Rybrevant work?
Drug information
Related support groups
- Tarceva (2 questions, 48 members)
- Erlotinib (2 questions, 10 members)
- Non-Small Cell Lung Cancer (53 questions, 73 members)